By contrast, ENO1 is a good prognostic marker in Stage 1 disease and clusters in the context of underexpression with a wide range of the pathways in histological subtypes of BC known to be associated with a good prognosis, such as mucinous and tubular carcinomas. This evidence concerns the gene ENO1 and breast cancer.